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	 A	 few	 new	 sulphadimidine	 incorporating	 thiophene	 moiety	 are	 synthesized.	 These
compounds	 were	 assessed	 by	 analytical	 and	 spectral	 data.	 Antioxidant	 evaluation	 for	 the
investigated	 compounds	 was	 evaluated	 by	 ABTS	 assay	 and	 bleomycin‐dependent	 DNA‐
damage;	the	compounds	exhibited	weak	activities.	
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1.	Introduction	
	
Sulphadrugs	 have	 attracted	 special	 attention	 from	 their	
therapeutic	 importance	 as	 they	 were	 used	 against	 a	 wide	
spectrum	 of	 bacterial	 aliments	 [1].	 Some	 sulphadrugs	 have	
been	 used	 in	 the	 treatment	 of	 cancer,	 malaria,	 leprosy	 and	
tuberculosis	[2,3].	Moreover,	many	thiophene	derivatives	were	
reported	 to	 exhibit	 different	 biological	 properties,	 such	 as	 A1	
adenosine	 receptor,	 allosteric	 enhancers	 [4,5],	 inhibitors	 of	
Human	 Leukocyte	 Elastase	 [6,7],	 antitumor	 [8],	 virucides,	
virostatic	 agent,	 [9],	 antitumor	 and	 anti‐HIV	 activities	 [4].	
Different	 methods	 were	 reported	 for	 the	 syntheses	 of	 azo	
sulphadrugs	[10‐15].	
Considering	 the	 facts	 that	 nearly	 all	 of	 the	 classes	 of	
heterocyclic	compounds	are	biologically	active	and	as	a	part	of	
our	 continuous	 efforts	 towards	 the	 development	 of	 more	
potent	antioxidant	agents	[16‐20].	It	was	thought	of	interest	to	
combine	 the	 above	 mentioned	 boilable	 rings	 together	 in	 a	
molecular	framework	to	investigate	the	additive	effect	of	these	
rings	towards	antioxidant	activity.	
	
2.	Experimental	
	
2.1.	Instrumentations	
All	melting	 points	 are	 determined	 on	 Gallenkamp	 electric	
melting	 point	 apparatus	 (uncorrected).	 Thin	 layer	
chromatography	 (TLC)	 analysis	 was	 carried	 out	 on	 silica	 gel	
60F254	 precoated	 aluminum	 sheets.	 The	 IR	 spectra	 were	
recorded	(KBr)	on	a	Mattson	5000	FTIR	Spectrophotometer	at	
the	 Microanalytical	 Unit,	 Faculty	 of	 Science,	 Mansoura	
University.	The	 1H	NMR	spectra	were	determined	on	a	Varian	
XL	200	MHz	 at	 the	Microanalytical	 Center,	 Faculty	 of	 Science,	
Cairo	 University,	 Egypt	 using	 DMSO‐d6	 as	 solvents	 and	
tetramethylsilane	 as	 internal	 standard.	 The	mass	 spectra	 (EI)	
were	 recorded	 on	 70	 eV	 with	 Kratos	 MS	 equipment	 at	 the	
Microanalytical	 Center,	 Cairo	 University,	 Egypt.	 Elemental	
analyses	 (C,	H	 and	N)	were	 carried	out	 at	 the	Microanalytical	
Center	 of	 Cairo	 University,	 Egypt.	 Biological	 activities	 were	
carried	 out	 at	 Pharmacognosy	 Department,	 Faculty	 of	
Pharmacy,	Mansoura	University,	Mansoura,	Egypt.	
	
2.2.	Synthesis	
	
2.2.1.	Synthesis	of	2‐cyano‐N‐(3‐cyano‐4‐phenylthiophen‐2‐
yl)acetamide	(4)	
	
A	 mixture	 of	 compound	 2	 (2.8	 g,	 14	 mmol)	 and	 3‐(3,5‐
dimethyl‐1H‐pyrazol‐1‐yl)‐3‐oxopropanenitrile	(3)	(2.39	g,	14		
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mmol)	 in	 benzene	 (20	mL)	was	 refluxed	 for	 8	 h.	 The	 solvent	
was	evaporated	under	vacuum	and	the	residue	was	crystallized	
form	ethanol	 to	 give	 carboxamide	4	 (Scheme	1	 and	2).	 Color:	
White	powder.	Yield:	44%.	M.p.:	230‐232	°C.	FT‐IR	(KBr,	ν,	cm‐
1):	3212	(NH),	2242,	2217	(2CN),	1693	(CO).	1H	NMR	(200	MHz,	
DMSO‐d6,	δ,	ppm):	4.24	(s,	2H,	CH2),	7.60‐8.42	(m,	6H,	Ar‐H,	C5‐
H	of	thiophene),	11.12	(brs.,	1H,	NHCO).	MS	(EI,	m/z	(%)):	269	
(M++2,	 1.3),	 268	 (M++1,	 3.6),	 267	 (M+,	 18.7),	 225	 (0.3),	 201	
(14.2),	200	(100.0),	172	(10.4),	168	(1.7),	155	(12.6),	146	(1.2),	
128	 (3.9),	 93	 (1.8),	 74	 (0.5).	 Anal.	 calcd.	 for	 C14H9N3OS	
(267.05):	C,	62.91;	H,	3.39;	N,	15.72%.	Found:	C,	62.88;	H,	3.45;	
N,	3.34%.	
	
2.2.2.	Synthesis	of	(E)‐3‐(4‐chlorophenyl)‐2‐cyano‐N‐(3‐
cyano‐4‐phenylthiophen‐2‐yl)	acrylamide	(6)	
	
A	mixture	of	 compound	4	 (1.3	g,	5	mmol),	piperidine	 (0.2	
mL)	and	p‐chlorobenzaldehyde	(0.7	g,	5	mmol);	in	ethanol	(15	
mL)	was	 stirred	 at	 80	 °C	 for	 1	 h.	 The	 separated	 crystals	was	
filtered,	 dried	 and	 recrystallized	 from	 ethanol	 to	 give	
compound	 6	 (Scheme	 2).	 Color:	 Orange	 powder.	 Yield:	 97%.	
M.p.:	198‐200	°C.	FT‐IR	(KBr,	ν,	 cm‐1):	3316	(NH),	2200,	2182	
(2CN),	1670	 (CO),	 700	 (C‐Cl).	 1H	NMR	 (200	MHz,	DMSO‐d6,	 δ,	
ppm):	 7.20‐	 7.85	 (m,	 11H,	 ArH	 +	 C5‐H	 of	 thiophene	 +	 CH=),	
11.44	(s,	br,	1H,	NH).	MS	(EI,	m/z	(%)):	389	(M+,	1.2),	366	(4.3),	
359	(38.7),	355	(9.1),	308	(4),	267	(3.6),	256	(15.0),	224	(5.9),	
200	 (100.0),	 174	 (13.0),	 163	 (45.8),	 135	 (7.9),	 128	 (7.5),	 99	
(16.6),	 89	 (7.9),	 67	 (1.2),	 60	 (25.7).	 Anal.	 calcd.	 for	
C21H12ClN3OS	 (389.04):	 C,	 64.70;	 H,	 3.10;	 N,	 10.78.	 Found:	 C,	
64.67;	H,	3.18;	N,	10.81%.	
	
2.2.3.	General	procedure	for	the	synthesis	of	aryl	
azothiophene	and	aryl	hydrazone	derivatives	8,	9,	10	and	12	
	
To	a	well‐stirred	cooled	solution	of	sulphadimidine	(1.5	g,	5	
mmol)	in	concentrated	HCl	(4	mL),	a	solution	of	NaNO2	(0.4	g,	5	
mmol	 in	 5	mL	 H2O)	was	 added	 drop	wise.	 The	 above	 cooled	
diazonium	solution	was	added	slowly	to	a	well‐stirred	solution	
of	compound	6	(1.94	g,	5	mmol),	2	(1	g,	5	mmol)	or	11	(1.38	g,	
5	mmol)	 in	pyridine	(15	mL)	or	4	 (1.34	g,	5	mmol)	 in	ethanol	
(30	 mL)	 containing	 sodium	 acetate	 (3.28	 g,	 40	 mmol).	 The	
reaction	mixture	 was	 stirred	 for	 2	 h.	 The	 crude	 product	 was	
filtered	off,	dried	well	and	recrystallized	from	the	appropriate	
solvent	 to	 afford	 compounds	 8,	 9,	 10	 and	 12,	 respectively	
(Scheme	2‐4).	
(E)‐3‐(4‐Chlorophenyl)‐2‐cyano‐N‐(3‐cyano‐5‐((E)‐(4‐(N‐
(4,6‐dimethylpyrimidin‐2‐yl)sulfamoyl)phenyl)diazenyl)‐4‐
phenylthiophen‐2‐yl)acrylamide	 (8):	 Color:	 Brown	 powder.	
Yield:	67%.	M.p.:	252‐254	°C.	FT‐IR	(KBr,	ν,	cm‐1):	3361,	3226	
(2NH),	2228,	2206	 (2CN),	1697	(CO),	1488	 (N=N),	700	 (C‐Cl).	
1H	 NMR	 (200	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 2.24	 (brs.,	 6H,	 2CH3),	
6.74	(s,	1H,	C5‐H	of	pyrimidine),	7.50‐8.37	(m,	14H,	Ar‐H+CH=),	
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11.35	 (brs.,	 1H,	 NHCO),	 12.28	 (brs.,	 1H,	 NHSO2).	 MS	 (EI,	m/z	
(%)):	 677	 (M+‐1,	 0.7),	 610	 (1.5),	 570	 (100.0),	 556	 (96.3),	 551	
(20.0),	 497	 (2.2),	 430	 (3.0),	 357	 (2.2),	 322	 (15.6),	 279	 (40.7),	
214	(39.3),	200	(30.4),	167	(45.9),	148	(94.8),	140	(14.1),	110	
(17),	88	(5.8),	69	(16.3).	Anal.	calcd.	for	C33H23ClN8O3S2	(678.1):	
C,	 58.36;	 H,	 3.41;	 N,	 16.50%.	 Found:	 C,	 58.40;	 H,	 3.49;	 N,	
16.45%.	
(E)‐4‐((5‐Amino‐4‐cyano‐3‐phenylthiophen‐2‐yl)diazenyl)‐N‐
(4,6‐dimethylpyrimidin‐2‐yl)benzenesulfonamide	 (9):	 Color:	
White.	Yield:	90%.	M.p.:	192‐194	°C.	FT‐IR	(KBr,	ν,	cm‐1):	3328,	
3286,	3235	 (NH2,	NH),	 2197	 (CN),	 1452	 (N=N).	 1H	NMR	 (200	
MHz,	DMSO‐d6,	δ,	ppm):	2.23	(brs.,	6H,	2CH3),	6.74	(s,	1H,	C5‐H	
of	 pyrimidine),	 7.43‐8.0	 (m,	 9H,	 Ar‐H),	 8.90	 (brs.,	 2H,	 NH2),	
11.95	(brs.,	1H,	NHSO2).	MS	(EI,	m/z	(%)):	492	(M++3,	0.3),	491	
(M++2,	 0.7),	 490	 (M++1,	 1.6),	 489	 (M+,	 4.3),	 459	 (0.3),	 425	
(53.3),	 407	 (0.8),	 382	 (1.5),	 350	 (0.4),	 318	 (8.2),	 303	 (10.2),	
289	 (3.4),	 246	 (3.7),	 227	 (6.5),	 213	 (80.6),	 198	 (33.9),	 155	
(16.5),	123	(100.0),	108	(22.1),	96	(33.8),	64	(59.6).	Anal.	calcd.	
for	C23H19N7O2S2	(489.1):	C,	56.43;	H,	3.91;	N,	20.03%.	Found:	C,	
56.49;	H,	3.83;	N,	20.10%.	
(E)‐2‐((3‐Cyano‐4‐phenylthiophen‐2‐yl)amino)‐N'‐(4‐(N‐(4,	
6‐dimethylpyrimidin‐2‐yl)sulfamoyl)phenyl)‐2‐oxoacetohydrazo	
noyl	 cyanide	 (10):	 Crystallization	 from	 a	 mixture	 of	
ethanol:benzene	 (3:1,	 v:v).	 Color:	 Yellow	 powder.	 Yield:	 61%.	
M.p.:	197‐199	°C.	FT‐IR	(KBr,	ν,	cm‐1):	3243,	3235,	3212	(3NH),	
2230,	2197	(2CN),	1673	(CO).	 1H	NMR	(200	MHz,	DMSO‐d6,	δ,	
ppm):	 2.25	 (br,	 6H,	 2CH3),	 6.76	 (s,	 1H,	 C5‐H	 of	 pyrimidine),	
7.44‐8.01	(m,	10H,	Ar‐H,	C5‐H	of	thiophene),	11.10	(br,	1H,	NH,	
hydrazone),	11.48	(brs.,	s,	1H,	NHCO),	12.30	(brs.,	1H,	NNHSO2).	
MS	 (EI,	 m/z	 (%)):	 407	 (M+‐(HCN+2‐imino‐4,5‐dimethyl	
pyrimidine),	398	(33.1),	373	(23.5),	356	(25.5),	337	(28.5),	320	
(31.3),	 293	 (30.6),	 275	 (25.8),	 245	 (35.6),	 213	 (42.5),	 200	
(83.6),	179	(54.6),	151	(28.1),	129	(34.1),	112	(41.7),	96	(58.7),	
83	(93.4),	69	(100.0).	Anal.	calcd.	for	C26H20N8O3S2	(556.11):	C,	
56.10;	H,	3.62;	N,	20.13.	Found:	C,	56.03;	H,	3.71;	N,	20.24%.	
(E)‐2‐Chloro‐N‐(3‐cyano‐5‐((4‐(N‐(4,6‐dimethylpyrimidin‐2‐
yl)sulfamoyl)phenyl)diazen‐yl)‐4‐phenylthiophen‐2‐yl)acetamide	
(12):	 Crystallization	 from	 DMF.	 Color:	 Orange	 powder.	 Yield:	
93%.	M.p.:	200‐202	°C.	FT‐IR	(KBr,	ν,	cm‐1):	3353,	3197	(2NH),	
2230	 (CN),	 1681	 (CO),	 1498	 (N=N),	 702	 (C‐Cl).	 1H	NMR	 (200	
MHz,	DMSO‐d6,	δ,	ppm):	2.23	(br.,	6H,	2CH3),	4.62	(s,	2H,	CH2Cl),	
6.73	(s,	1H,	C5‐H	of	pyrimidine),	7.55‐8.08	(m,	9H,	Ar‐H),	11.40	
(brs.,	 1H,	 NHCO),	 12.30	 (brs.,	 1H,	 NHSO2).	 MS	 (EI,	m/z	 (%)):	
488	 (M+‐COCH2Cl,	 0.1),	 467	 (0.1),	 411	 (0.3),	 382	 (0.5),	 358	
(0.2),	335	(0.2),	304	(0.9),	276	(0.4),	235	(0.5),	214	(11.2),	198	
(3.9),	170	(0.9),	140	(2.0),	123	(100.0),	108	(8.8),	95	(47.0),	82	
(36.3),	 64	 (54.7),	 45	 (20.3).	 Anal.	 calcd.	 for	 C25H20ClN7O3S2	
(565.08):	C,	53.05;	H,	3.56;	N,	17.32.	Found:	C,	52.96;	H,	3.63;	N,	
17.42%.	
	
2.2.4.	Synthesis	of	(E)‐2‐(benzo[d]thiazol‐2‐ylthio)‐N‐(3‐
cyano‐5‐((4‐(N‐(4,6‐dimethylpyrimidin‐2‐yl)sulfamoyl)	
phenyl)diazenyl)‐4‐phenylthiophen‐2‐yl)acetamide	(14)	
	
A	 mixture	 from	 compound	 12	 (2.82	 g,	 5	 mmol)	 and	 2‐
mercaptothiazole	 (13)	 (0.83	 g,	 5	 mmol)	 in	 pyridine	 (15	 mL)	
was	refluxed	for	5	h.	The	reaction	mixture	was	left	to	cool	and	
poured	in	ice	cold	water.	The	precipitated	solid	was	filtered	off,	
dried	 and	 crystallized	 from	 ethanol	 to	 give	 compound	 14	
(Scheme	4).	Color:	Black	powder.	Yield:	60%.	M.p.:	230‐232	°C.	
FT‐IR	(KBr,	ν,	cm‐1):	3342,	3262	(2NH),	2204	(CN),	1727	(CO),	
1494	(N=N).	1H	NMR	(200	MHz,	DMSO‐d6,	δ,	ppm):	2.24	(br,	6H,	
2CH3),	3.10	(s,	2H,	CH2),	6.74	(s,	1H,	C5‐H	of	pyrimidine),	7.29‐
7.99	 (m,	 13H,	 Ar‐H),	 11.50	 (brs.,	 1H,	 NHCO),	 12.48	 (br.,	 1H,	
NHSO2).	MS	 (EI,	m/z	 (%):	 696	 (M+,	 7.1),	 620	 (6.3),	 600	 (3.8),	
572	(5.7),	532	(4.3),	489	(4.7),	451	(4.0),	410	(4.5),	361	(4.9),	
332	 (6.1),	 289	 (5.9),	 252	 (12.3),	 220	 (6.5),	 208	 (12.7),	 190	
(4.7),	 180	 (20.8),	 167	 (73.7),	 140	 (4.0),	 122	 (4.7),	 108	 (22.7),	
86	 (7.7),	 72	 (100.0),	 58	 (18.0).	 Anal.	 calcd.	 for	 C32H24N8O3S4	
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(696.84):	C,	55.15;	H,	3.47;	N,	16.08.	Found:	C,	55.23;	H,	3.51;	N,	
16.17%.	
	
2.3.	Antioxidant	activity	
	
2.3.1.	ABTS	screening	assay	
	
Antioxidant	 activity	 determinations	 were	 evaluated	 from	
the	bleaching	of	ABTS	derived	radical	cations	[21].	The	radical	
cation	 derived	 from	 ABTS	 (2,2’‐Azino‐bis‐(3‐ethyl	 benzo	
thiazoline‐6‐sulfonic	 acid))	was	prepared	by	 reaction	of	ABTS	
(60	mL)	with	MnO2	(3	mL,	25	mg/mL)	in	5	mL	aqueous	buffer	
solution	(pH	=	7).	After	shaking	the	solution	for	a	few	minutes,	
it	was	centrifuged	and	 filtered.	The	Absorbance	(A	control)	of	
the	 resulting	 green‐blue	 solution	 (ABTS	 radical	 solution)	was	
recorded	 at	 max	 734	 nm.	 The	 absorbance	 (A	 test)	 was	
measured	upon	the	addition	of	(20	mL	of	1	mg/mL)	solution	of	
the	tested	sample	in	spectroscopic	grade	MeOH:buffer	(1:1,	v:v)	
to	 the	 ABTS	 solution.	 The	 inhibition	 ratio	 (%)	was	 calculated	
using	the	equation	1.		
	
Inhibition	(%)	=	[A	(control)–A	(test)/A	(control)]×100	 	(1)	
	
Ascorbic	 acid	 (20	 mL,	 2	 mM)	 solution	 was	 used	 as	 a	
standard	antioxidant	 (positive	control).	Blank	sample	was	run	
using	solvent	without	ABTS	(Table	1).	
	
Table	1.	ABTS	antioxidant	activity	assay	for	the	thiophene	derivatives.	
Compound	 Absorbance	of	samples	 Inhibition	%	
8	 0.469	 1.05
9	 0.445	 6.11
10	 0.403	 14.90
12	 0.452	 4.64	
14	 0.370	 21.94	
Ascorbic	acid	 0.048	 89.87	
Control	of	ABTS	 0.474	 0
	
	
2.3.2.	Bleomycin‐dependent	DNA‐damage	
	
The	assay	was	done	according	to	Aeschbach	et	al.,	[22]	and	
Chan	 &	 Tang	 [23]	 with	 minor	 modifications.	 The	 reaction	
mixture	 (0.5	 mL)	 contained	 DNA	 (0.5	 mg/mL),	 bleomycin	
sulfate	 (0.05	mg/mL),	 and	MgCl2	 (5	mM),	 FeCl3	 (50	mM)	 and	
the	 samples	 were	 dissolved	 in	 DMSO	 to	 be	 tested	 at	
concentration	(20	mL	of	1	mg/mL).	L‐Ascorbic	acid	was	used	as	
a	positive	control.	The	mixture	was	incubated	at	37	°C	for	1	h.	
The	reaction	was	terminated	by	addition	of	0.05	mL	EDTA	(0.1	
M).	 The	 color	 was	 developed	 by	 adding	 thiobarbituric	 acid	
(TBA)	(0.5	mL)	(1%,	w:v)	and	HCl	(0.5	mL)	(25%,	v:v)	followed	
by	heating	at	80	°C	for	10	min.	After	centrifugation,	the	extent	
of	DNA	damage	was	measured	by	the	increase	in	absorbance	at	
532	nm	(Table	2).	
	
Table	2.	Bleomycin	dependent‐DNA	damage	of	thiophene	derivatives.	
Compound	 Absorbance	of	samples	
8	 0.135	
9	 0.128	
10	 0.119	
12	 0.141	
14	 0.112	
Ascorbic	acid	 0.097	
	
	
3.	Results	and	discussion		
	
3.1.	Chemistry	
	
The	 synthetic	 strategies	 adopted	 to	 obtain	 the	 target	
compounds	 are	 depicted	 in	 Schemes	1‐4.	 Starting	 compounds	
2‐(1‐phenylethylidene)malononitrile	(1)	and	2‐amino‐3‐cyano‐
4‐phenylthiophene	 (2)	 were	 prepared	 according	 to	 the	
reported	procedures	[24,25],	as	outlined	in	Scheme	1.	
Cyanoacetylation	 of	 enaminonitrile	 derivative	2	 [25]	with	
3‐(3,5‐dimethyl‐1H‐pyrazol‐1‐yl)‐3‐oxopropanenitrile	 (3)	 [26]	
afforded	2‐cyano‐N‐(3‐cyano‐4‐phenylthiophen‐2‐yl)acetamide	
(4),	 the	 reaction	 proceeded	 according	 to	 previously	 reported	
method	 [27].	 Furthermore,	 reaction	 of	 compound	 4	 with	 p‐
chlorobenzaldehyde	 (5)	 afforded	 corresponding	 arylidene	
derivative	 6	 which	 further	 coupled	 with	 sulphadimidine	
diazonium	 salt	 7	 in	 pyridine	 to	 give	 the	 corresponding	 aryl	
azothiophene	 derivative	 8.	 Moreover,	 coupling	 of	 thiophene	
derivative	 2	 with	 diazonium	 salt	 7	 in	 pyridine	 afforded	 aryl	
azothiophene	derivative	9	(Scheme	2).	
Structures	 of	 compounds	4,	6,	8	 and	9	 were	 assessed	 by	
analytical	and	spectral	data	(IR,	1H	NMR	and	mass	spectra).	The	
IR	 spectra	 of	 compounds	 4,	 6,	 8	 and	 9	 showed	 absorption	
bands	within	ν	3361‐3212	cm‐1	due	to	symmetric	vibrations	of	
NH2	 and	NH	 groups,	 in	 addition	 to	 absorption	bands	within	 ν	
2242‐2182	 cm‐1	 corresponding	 to	 cyano	 functions	 and	
absorption	 bands	 within	 ν	 1697‐1670	 cm‐1	 due	 to	 carbonyl	
groups.	
The	1H	NMR	spectrum	of	compound	4	displayed	signals	at	δ	
4.24	 (s,	 2H,	 CH2),	 7.60‐8.42	 (m,	 6H,	 Ar‐H,	 C5‐H,	 thiophene),	
11.12	 (brs.,	 1H,	NHCO)	 ppm.	 On	 the	 other	 hand,	 the	 1H	NMR	
spectrum	of	compound	8	displayed	signals	at	δ	2.24	(brs.,	6H),	
6.74	 (s,	 1H),	 7.50‐8.37	 (m,	 13H),	 11.35	 (brs.,	 1H),	 12.28	 ppm	
(brs.,	 1H)	ppm	due	 to	 two	CH3,	 C5‐H	 of	 pyrimidine,	 aromatic,	
NHCO	and	NHSO2	protons,	respectively.	Moreover,	the	1H	NMR	
spectrum	of	compound	9	displayed	signals	at	δ	2.23	(brs.,	6H),	
6.74	(s,	1H),	7.43‐8.00	(m,	9H),	8.90	(br,	2H),	11.95	ppm	(brs,	
1H)	corresponding	to	two	CH3,	C5‐H,	pyrimidine,	aromatic,	NH2	
and	NHSO2	protons,	respectively.	
The	 mass	 spectrum	 of	 compound	 4	 gave	 an	 additional	
evidence	for	structure	elucidation	which	showed	the	molecular	
ion	peaks	at	m/z	269	(M++2),	268	(M++1),	267	(M+)	 that	 is	 in	
agreement	with	the	molecular	formula	(C14H9N3OS),	in	addition	
to	 the	 base	 peak	 at	m/z	 200	 attributed	 to	 (M+‐[COCH2CN]).	
Also,	the	mass	spectrum	of	compound	6	showed	the	molecular	
ion	peak	at m/z	389	that	is	adopted	with	the	molecular	formula	
(C21H12ClN3OS),	in	addition	to	the	base	peak	at	m/z	200	due	to	
2‐amino‐4‐phenylthiophene‐3‐carbonitrile	 moiety.	 Moreover,	
the	mass	 spectrum	of	 compound	8	 showed	 the	molecular	 ion	
peak	 at	 m/z	 677	 (M+‐1,	 0.7)	 which	 in	 agreement	 with	 the	
molecular	 formula	 (C33H23ClN8O3S2),	 in	 addition	 to	 the	 base	
peak	 at m/z	 570	 attributed	 to	 (M+‐(dimethylpyrimidine)).	
Moreover,	 the	 mass	 spectrum	 of	 compound	 17	 showed	 four	
molecular	 ion	 peaks	 at	 m/z	 492,	 491,	 490	 and	 489	
corresponding	 to	 (M++3),	 (M++2),	 (M++1)	 and	 (M+),	 respect‐
tively,	 which	 are	 in	 agreement	 with	 the	 molecular	 formula	
(C23H19N7O2S2),	in	addition	to	the	base	peak	at	m/z	123	that	is	
related	to	2‐aminodimethylpyrimidine	moiety.	
Moreover,	 coupling	 of	 cyanoacetamide	 derivative	 4	 with	
diazonium	salt	7	in	ethanol	containing	sodium	acetate	afforded	
the	 corresponding	 hydrazone	 derivative	 10	 (Scheme	 3).	
Assignment	 of	 structure	 10	 was	 based	 on	 analytical	 and	
spectral	data	(IR,	1H	NMR	and	mass	spectra).	The	IR	spectrum	
showed	absorption	bands	 at	 ν	3243,	 3235,	 3212,	 2230,	 2197,	
1673	cm‐1	corresponding	to	(3NH),	(2CN)	and	carbonyl	groups,	
respectively.	 Furthermore,	 the	 1H	 NMR	 spectrum	 displayed	
signals	 at	 δ	 2.25	 (brs.,	 6H),	 11.10	 (brs.,	 1H)	 and	 12.30	 ppm	
(brs.,	 1H)	ppm	corresponding	 to	 two	CH3,	NH,	hydrazone	and	
NHSO2	 protons,	 respectively.	 Moreover,	 its	 mass	 spectrum	
showed	four	molecular	ion	peaks	at	m/z	407,	262,	199	and	122	
corresponding	 to	 (M+(HCN+2‐imino‐4,5‐dimethylpyrimidine),	
4‐[(N‐(4,6‐dimethyl‐pyrimidin‐2‐yl)sulfon‐amide]phenyl,	 2‐
amino‐4‐phenylthiophene‐3‐carbonitrile	 and	 2‐imino‐4,5‐
dimethyl	pyrimidine,	respectively,	in	addition	to	the	base	peak	
at	m/z	69	which	is	related	to	propiononitrile	moiety.	
Treatment	 of	 compound	 2	 with	 chloroacetyl	 chloride	
according	 to	 the	 previously	 reported	 method	 afforded	 the	
chloroacetamide	 derivative	 11	 [28]	 which	 coupled	 with	
diazonium	 salt	 7	 in	 pyridine	 to	 afforded	 the	 hydrazone	
derivative	12.		
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Figure	1.	Structure	activity	relationship’s	(SAR’s)	of	the	more	potent	compounds.
	
	
Reaction	 of	 compound	12	 with	 2‐mercapto	 benzothiazole	
13	 in	 refluxing	 pyridine	 yielded	 thiazole	 derivative	 14	 as	
outlined	in	Scheme	4.	Assignment	of	compounds	12	and	14	was	
based	 on	 correct	 IR,	 1H	 NMR	 and	mass	 spectral	 data.	 The	 IR	
spectra	 showed	 absorption	 bands	 within	 ν	 3353‐3197	 and	
1727‐1681	 cm‐1	 due	 to	 the	 stretching	 vibrations	 of	 NH	 and	
carbonyl	groups,	respectively,	absorption	bands	within	ν	1498‐
1494	 cm‐1	 corresponding	 to	 symmetric	 vibrations	 of	 azo	
groups,	 in	 addition	 to	 absorption	 bands	 within	 ν	 2230‐2204	
cm‐1	are	attributed	to	cyano	groups	of	the	coupler	moieties.	The	
1H	NMR	spectrum	of	compound	12	displayed	signals	at	δ	2.23	
(brs.,	 6H),	 4.62	 (s,	 2H),	 6.73	 (s,	 1H),	 7.55‐8.08	 (m,	 9H),	 11.40	
(br,	 1H),	 12.30	 (br,	 1H)	 ppm	 due	 to	 two	 CH3,	 CH2Cl,	 C5‐H,	
pyrimidine,	 aromatic,	NHCO	 and	NHSO2	 protons,	 respectively.	
On	 the	 other	 hand,	 the	 1H	 NMR	 spectrum	 of	 compound	 14	
revealed	signals	at	δ	2.24	(brs.,	6H),	3.10	(s,	2H),	6.74	(s,	1H),	
7.29‐7.99	(m,	13H),	11.50	(brs.,	1H),	12.48	(brs.,	1H)	ppm	due	
to	two	CH3,	CH2,	C5‐H,	pyrimidine,	aromatic,	NHCO	and	NHSO2	
protons,	 respectively.	 The	 mass	 spectrum	 of	 compound	 12	
showed	 the	 molecular	 ion	 peak	 at	 m/z	 488	 which	 is	
equivalence	 to	 (M+‐COCH2Cl),	 in	 addition	 to	 the	 base	peak	 at 
m/z	123	which	 is	assigned	 to	2‐imino‐4,5‐dimethylpyrimidine	
moiety.	Moreover,	the	mass	spectrum	of	compound	14	showed	
the	molecular	ion	peak	at	m/z	696	(M+)	which	is	in	agreement	
with	the	molecular	formula	(C32H24N8O3S4).	
	
3.2.	Biological	activity	
	
3.2.1.	Antioxidant	activity	assay	
	
The	 antioxidant	 activities	 for	 five	 thiophene	 derivatives	
were	 evaluated	 as	 reported	 method	 by	 Lissi	 et	 al.	 [21].	 The	
results	outlined	in	Table	1	showed	clearly	that	the	investigated	
compounds	exhibited	weak	activities.	
		
3.2.2.	Bleomycin‐dependent	DNA‐damage	
	
Five	 thiophene	 derivatives	 were	 selected	 for	 bleomycin‐
dependent	DNA‐damage	screening	(Table	2).	Damage	of	DNA	in	
the	presence	of	a	bleomycin‐Fe	complex	has	been	adopted	as	a	
sensitive	and	specific	method	to	examine	potential	pro‐oxidant	
agents	 [29].	 If	 the	 tested	 samples	 are	 able	 to	 reduce	 the	
bleomycin‐Fe3+	and	Fe2+	to	bleomycin‐Fe2+,	DNA	degradation	in	
this	 system	will	 be	 stimulated,	 resulting	 in	 a	 positive	 test	 for	
pro‐oxidant	activity.	Degradation	of	DNA	is	accompanied	by	the	
formation	 of	 a	 product	 similar	 to	 malondialdehyde	 (MDA).							
L‐Ascorbic	acid	as	a	reducing	agent	can	reduce	Fe3+ 	to	Fe2+ .	The	
results	outlined	 in	Table	2	showed	 that	all	of	 the	 investigated	
compounds	exhibited	weak	activities.	
By	 comparing	 the	 results	 obtained	 of	 antioxidant	 of	 the	
compounds	 reported	 in	 this	 study	 to	 their	 structures,	 the	
following	 structure	 activity	 relationship’s	 (SAR’s)	 were	
postulated:		
(i) Cyanoacetamide	10	 is	more	potent	than	thiophene	9	
which	 may	 be	 attributable	 to	 presence	 of	
cyanoacetamide	moiety.		
(ii) Compound	14	 is	more	 potent	 than	 chloroacetamide	
12	which	may	be	due	to	replacement	of	chlorine	atom	
by	mercaptothiazole	moiety	(Figure	1).	
	
4.	Conclusion	
	
The	 objective	 of	 the	 present	 study	was	 to	 synthesize	 and	
evaluate	the	antioxidant	activity	of	some	novel	sulphadimidine	
incorporating	 thiophene	moiety	with	 the	 hope	 of	 discovering	
new	 structure	 leads	 serving	 as	 antioxidant	 agents.	 The	 data	
clearly	showed	that	all	of	the	investigated	compounds	exhibited	
weak	anti‐oxidant	activities.		
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